1211 related articles for article (PubMed ID: 28389532)
1. RNA-binding proteins with prion-like domains in health and disease.
Harrison AF; Shorter J
Biochem J; 2017 Apr; 474(8):1417-1438. PubMed ID: 28389532
[TBL] [Abstract][Full Text] [Related]
2. Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease.
March ZM; King OD; Shorter J
Brain Res; 2016 Sep; 1647():9-18. PubMed ID: 26996412
[TBL] [Abstract][Full Text] [Related]
3. Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.
Guo L; Shorter J
Cold Spring Harb Perspect Med; 2017 Sep; 7(9):. PubMed ID: 27920024
[TBL] [Abstract][Full Text] [Related]
4. Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains.
Guo L; Kim HJ; Wang H; Monaghan J; Freyermuth F; Sung JC; O'Donovan K; Fare CM; Diaz Z; Singh N; Zhang ZC; Coughlin M; Sweeny EA; DeSantis ME; Jackrel ME; Rodell CB; Burdick JA; King OD; Gitler AD; Lagier-Tourenne C; Pandey UB; Chook YM; Taylor JP; Shorter J
Cell; 2018 Apr; 173(3):677-692.e20. PubMed ID: 29677512
[TBL] [Abstract][Full Text] [Related]
5. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.
Kim HJ; Kim NC; Wang YD; Scarborough EA; Moore J; Diaz Z; MacLea KS; Freibaum B; Li S; Molliex A; Kanagaraj AP; Carter R; Boylan KB; Wojtas AM; Rademakers R; Pinkus JL; Greenberg SA; Trojanowski JQ; Traynor BJ; Smith BN; Topp S; Gkazi AS; Miller J; Shaw CE; Kottlors M; Kirschner J; Pestronk A; Li YR; Ford AF; Gitler AD; Benatar M; King OD; Kimonis VE; Ross ED; Weihl CC; Shorter J; Taylor JP
Nature; 2013 Mar; 495(7442):467-73. PubMed ID: 23455423
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis.
Couthouis J; Hart MP; Erion R; King OD; Diaz Z; Nakaya T; Ibrahim F; Kim HJ; Mojsilovic-Petrovic J; Panossian S; Kim CE; Frackelton EC; Solski JA; Williams KL; Clay-Falcone D; Elman L; McCluskey L; Greene R; Hakonarson H; Kalb RG; Lee VM; Trojanowski JQ; Nicholson GA; Blair IP; Bonini NM; Van Deerlin VM; Mourelatos Z; Shorter J; Gitler AD
Hum Mol Genet; 2012 Jul; 21(13):2899-911. PubMed ID: 22454397
[TBL] [Abstract][Full Text] [Related]
7. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.
King OD; Gitler AD; Shorter J
Brain Res; 2012 Jun; 1462():61-80. PubMed ID: 22445064
[TBL] [Abstract][Full Text] [Related]
8. De novo design of RNA-binding proteins with a prion-like domain related to ALS/FTD proteinopathies.
Mitsuhashi K; Ito D; Mashima K; Oyama M; Takahashi S; Suzuki N
Sci Rep; 2017 Dec; 7(1):16871. PubMed ID: 29203801
[TBL] [Abstract][Full Text] [Related]
9. From Prions to Stress Granules: Defining the Compositional Features of Prion-Like Domains That Promote Different Types of Assemblies.
Fomicheva A; Ross ED
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513942
[TBL] [Abstract][Full Text] [Related]
10. Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma.
Ryan JJ; Sprunger ML; Holthaus K; Shorter J; Jackrel ME
J Biol Chem; 2019 Jul; 294(29):11286-11296. PubMed ID: 31171724
[TBL] [Abstract][Full Text] [Related]
11. Nuclear-Import Receptors Counter Deleterious Phase Transitions in Neurodegenerative Disease.
Odeh HM; Fare CM; Shorter J
J Mol Biol; 2022 Jan; 434(1):167220. PubMed ID: 34464655
[TBL] [Abstract][Full Text] [Related]
12. Role of FET proteins in neurodegenerative disorders.
Svetoni F; Frisone P; Paronetto MP
RNA Biol; 2016 Nov; 13(11):1089-1102. PubMed ID: 27415968
[TBL] [Abstract][Full Text] [Related]
13. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
[TBL] [Abstract][Full Text] [Related]
14. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis.
Mackenzie IR; Neumann M
Brain Res; 2012 Jun; 1462():40-3. PubMed ID: 22261247
[TBL] [Abstract][Full Text] [Related]
15. Altered mRNP granule dynamics in FTLD pathogenesis.
Bowden HA; Dormann D
J Neurochem; 2016 Aug; 138 Suppl 1():112-33. PubMed ID: 26938019
[TBL] [Abstract][Full Text] [Related]
16. RNA as the stone guest of protein aggregation.
Louka A; Zacco E; Temussi PA; Tartaglia GG; Pastore A
Nucleic Acids Res; 2020 Dec; 48(21):11880-11889. PubMed ID: 33068411
[TBL] [Abstract][Full Text] [Related]
17. Perfecting prediction of mutational impact on the aggregation propensity of the ALS-associated hnRNPA2 prion-like protein.
Batlle C; Fernández MR; Iglesias V; Ventura S
FEBS Lett; 2017 Jul; 591(13):1966-1971. PubMed ID: 28542905
[TBL] [Abstract][Full Text] [Related]
18. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
[TBL] [Abstract][Full Text] [Related]
19. Mutations in human prion-like domains: pathogenic but not always amyloidogenic.
Bartolomé-Nafría A; García-Pardo J; Ventura S
Prion; 2024 Dec; 18(1):28-39. PubMed ID: 38512820
[TBL] [Abstract][Full Text] [Related]
20. A minimal construct of nuclear-import receptor Karyopherin-β2 defines the regions critical for chaperone and disaggregation activity.
Fare CM; Rhine K; Lam A; Myong S; Shorter J
J Biol Chem; 2023 Feb; 299(2):102806. PubMed ID: 36529289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
